This inventor holds 2 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Vincent H J Leonard: Innovator in Cancer Treatment
Introduction
Vincent H J Leonard is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for cancer patients. With a total of 2 patents, his work focuses on utilizing viruses for therapeutic purposes.
Latest Patents
Leonard's latest patents include groundbreaking research on viruses lacking epithelial cell receptor entry. The documents detail the provision of nucleic acids, polypeptides, and viruses that contain these nucleic acids and/or polypeptides. Specifically, the patents describe methods for using these viruses to treat cancer patients. The nucleic acid molecules encode viral hemagglutinin (H) polypeptides, which are crucial for the development of effective vaccinations and cancer treatments. Notably, these viruses are designed to be non-shedding, enhancing their safety and efficacy in clinical applications.
Career Highlights
Vincent H J Leonard is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in virology and cancer treatment. His innovative approach has positioned him as a key figure in the medical research community.
Collaborations
Leonard collaborates with esteemed colleagues, including Roberto Cattaneo, to further enhance the impact of his research. Their combined expertise contributes to the development of novel therapeutic strategies.
Conclusion
Vincent H J Leonard's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patents and collaborations reflect a commitment to improving patient outcomes through advanced therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
